Stay updated with breaking news from Brian Strem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kiora Pharmaceuticals (NASDAQ:KPRX) CEO Brian Strem joined Steve Darling from Proactive to share news the company's plan to broaden the clinical development...
Kiora Pharmaceuticals has been granted US and European patents covering local ocular delivery of the KIO-100 family of non-steroidal, anti-inflammatory small molecules.
Shares of Kiora Pharmaceuticals, Inc. (KPRX) are up 13% on Wednesday after the company was issued U.S. and European Patents for local ocular delivery of the KIO-100 family of non-steroidal, anti-inflammatory small molecules.
Salt Lake City, Utah--(Newsfile Corp. - January 5, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022. Brian Strem